Anti-CYP2A13 antibody
产品特性
| Product Cat#: | AB-06-1247 | |||||
| Product type: | Primary antibody | |||||
| Antigen: | CYP2A13 | |||||
| Immunogen: | KLH conjugated synthetic peptide derived from human CYP2A13 301-400/494 | |||||
| Species immunized: | Rabbit | |||||
| Isotype: | IgG | |||||
| Applications: | Western Blot (1:500-1:2000) | |||||
| Reactivity: | Human | |||||
| Clonality (clone number): | Polyclonal | |||||
| Form: | Liquid | |||||
| Buffer: | 10mM Tris-HCl buffer (pH7.4), 1% BSA, 50% glycerol, 0.03% Proclin300. | |||||
| Concentration: | 1 mg/ml | |||||
| Purity: | Protein A affinity purified | |||||
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. | |||||
| Alternative names: | CP2AD_HUMAN | CPAD | CYP2A | CYP2A13 | CYPIIA13 | Cytochrome P450 2A13 |
展开
靶标信息
Exhibits a coumarin 7-hydroxylase activity. Active in the metabolic activation of hexamethylphosphoramide, N,N-dimethylaniline, 2′-methoxyacetophenone, N-nitrosomethylphenylamine, and the tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Possesses phenacetin O-deethylation activity.
产品来源
洱畔科技实验室
